Diagnostic Performance of Von Willebrand Activity Versus Ristocetin Cofactor Tests in the Primary Evaluation of Von Willebrand Disease in Colombia
Clinical and Applied Thrombosis/Hemostasis · 2025-08 · 31
DOI: 10.1177/10760296251401583 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 18.12.2025. Verfasst von Marcela Godoy-Corredor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Pathology Laboratory, Clinica Colsanitas, Grupo Keralty, Bogotá, Colombia. Hauptthemen laut MEDLINE: von Willebrand Diseases, von Willebrand Factor, Ristocetin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinica Colsanitas.
Abstract (Originalsprache)
Background
Accurate diagnosis of Von Willebrand Disease (VWD) is essential for effective management, but no single test can definitively confirm it due to the disease's complexity and the limitations of current methods. Tests measuring Von Willebrand Factor (VWF) binding activity, such as the platelet-dependent VWF activity test (VWF:Ab), have been developed, but their application in Latin American populations remains underexplored. This study aimed to evaluate the performance of the VWF:Ab test compared to the Ristocetin Cofactor test (VWF:GPIbR) in a Colombian population with suspected or confirmed VWD.
Methods
A diagnostic cross-sectional and retrospective study was conducted, including adults referred for hematological evaluation due to a personal or family history of bleeding disorders. Samples were analyzed using both VWF:GPIbR and VWF:Ab tests (HemosIL ® ) simultaneously. Diagnostic performance was assessed through sensitivity, specificity, predictive values. Additionally, correlation analyses were performed, and the level of agreement at various diagnostic thresholds was assessed.
Results
125 patients were included, 88% of whom were women. A strong positive correlation was found between both tests (ICC = 0.96, p < 0.001). VWF:Ab had a specificity of 98.8% and sensitivity of 71.4%. Degree of agreement for 89.6% threshold was Normal (Greater than 50 IU/dL), Pathological (Less than 50.0 IU/dL). Notably, 7.2% of samples were classified as unclassifiable by VWF:Ab, highlighting potential limitations in qualitative defect detection Conclusion VWF:Ab exhibited high specificity and a strong correlation with VWF:GPIbR. Nevertheless, the differences in subtype classification and the identification of unclassifiable samples underscore the necessity of using both tests in a complementary manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Pathology Laboratory, Clinica Colsanitas, Grupo Keralty, Bogotá, Colombia.
- Research Unit. INPAC Research Group, Fundación Universitaria Sanitas, Bogotá, Colombia.
- Member of the Von Willebrand Committee Latin American Group of Thrombosis and Hemostasis, Bogotá, Colombia.
ORCID-Profile: Claudia C Colmenares-Mejia, Natalia Gomez-Lopera
Förderung
- Clinica Colsanitas
Zitieren
APA
Godoy-Corredor, M., Colmenares-Mejia, C. C., Reina-Soler, A. M., Gomez-Lopera, N., Gaitán, A. L., Ruiz-Amaya, D. A., Gutiérrez-Urueña, X., & Isaza-Ruget, M. A. (2025). Diagnostic Performance of Von Willebrand Activity Versus Ristocetin Cofactor Tests in the Primary Evaluation of Von Willebrand Disease in Colombia. Clinical and Applied Thrombosis/Hemostasis, 31. https://doi.org/10.1177/10760296251401583
Vancouver
Godoy-Corredor M, Colmenares-Mejia CC, Reina-Soler AM, Gomez-Lopera N, Gaitán AL, Ruiz-Amaya DA, et al. Diagnostic Performance of Von Willebrand Activity Versus Ristocetin Cofactor Tests in the Primary Evaluation of Von Willebrand Disease in Colombia. Clinical and Applied Thrombosis/Hemostasis. 2025;31. doi:10.1177/10760296251401583
BibTeX
@article{GodoyCorredor2025,
author = {Godoy-Corredor, Marcela and Colmenares-Mejia, Claudia C and Reina-Soler, Aura M and Gomez-Lopera, Natalia and Gaitán, Adriana Lozano- and Ruiz-Amaya, Diego A and Gutiérrez-Urueña, Ximena and Isaza-Ruget, Mario A},
title = {Diagnostic Performance of Von Willebrand Activity Versus Ristocetin Cofactor Tests in the Primary Evaluation of Von Willebrand Disease in Colombia},
journal = {Clinical and Applied Thrombosis/Hemostasis},
year = {2025},
volume = {31},
doi = {10.1177/10760296251401583}
}
EUVIMED